GlassScriptPhysician profile
Tom B Brumitt
NPI 1215943535
$1,800.51
in general payments reported to CMS, 2019-2025
11 companies · $116 in 2025
The $116 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,233 · 2020: $116 · 2021: $161 · 2022: $42.34 · 2023: $24.59 · 2024: $108 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,146.52 | 2019 | |
| Bard Peripheral Vascular, INC. | $131.95 | 2020-2021 | |
| Medtronic, INC. | $126.43 | 2021-2024 | Concertotm |
| Medtronic Vascular, INC. | $104.52 | 2019-2020 | |
| Boston Scientific Corporation | $83.95 | 2024-2025 | Eluvia, Ranger |
| Inari Medical, INC. | $77.21 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $40.42 | 2019 | |
| Cook Medical LLC | $24.09 | 2024 | Cook |
| Janssen Biotech, INC. | $22.94 | 2024 | Tremfya |
| Argon Medical Devices, INC. | $22.28 | 2020 | |
| Angiodynamics, INC. | $20.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Brumitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.